These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 39405376)

  • 1. Influencing Factors of Urinary Iodine Concentration Before and After Radioiodine Therapy for Differentiated Thyroid Cancer: An Initial Exploration of the Relationship With Therapeutic Efficacy.
    Liu Q; Zhou H; Xia Y; Huang Y; Liu L; Jiang X; Shi Y
    Cancer Control; 2024; 31():10732748241292786. PubMed ID: 39405376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum thyrotropin level of 30 μIU/mL is inadequate for preablative thyroglobulin to serve as a prognostic marker for differentiated thyroid cancer.
    Zhao T; Liang J; Guo Z; Li J; Lin Y
    Endocrine; 2016 Jul; 53(1):166-73. PubMed ID: 26782372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Only peak thyroglobulin concentration on day 1 and 3 of rhTSH-aided RAI adjuvant treatment has prognostic implications in differentiated thyroid cancer.
    Ledwon A; Paliczka-Cieślik E; Syguła A; Olczyk T; Kropińska A; Kotecka-Blicharz A; Hasse-Lazar K; Kluczewska-Gałka A; Jarząb B; Handkiewicz-Junak D
    Ann Nucl Med; 2021 Nov; 35(11):1214-1222. PubMed ID: 34363597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is Stimulated Thyroglobulin Before Radioiodine Therapy a Useful Tool in Predicting Response to Initial Therapy in Patients with Differentiated Thyroid Carcinoma?
    Jaeger F; Eidt LB; Guidolin K; Landenberger GMC; Bündchen C; Golbert L; Mattevi VS; Meyer ELS
    Horm Metab Res; 2024 Sep; 56(9):641-648. PubMed ID: 38772391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive Value of Thyroglobulin Changes for the Curative Effect of Radioiodine Therapy in Patients With Metastatic Differentiated Thyroid Carcinoma.
    Wang C; Zhang R; Wang R; Meng Z; Zhang G; Dong F; He Y; Tan J
    Front Endocrinol (Lausanne); 2021; 12():667544. PubMed ID: 34040584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary iodine concentration and radioactive iodine therapeutic response in patients with differentiated thyroid cancer.
    Jiang Y; Jin J; Fan J; Huang C; Jia Q; Tan J; He X; Zheng X; Zhao Y; Zhang Q; Meng Z; Wang Y
    Biomark Med; 2021 Aug; 15(11):879-890. PubMed ID: 34241549
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum thyroglobulin concentrations predict disease-free remission and death in differentiated thyroid carcinoma.
    Heemstra KA; Liu YY; Stokkel M; Kievit J; Corssmit E; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2007 Jan; 66(1):58-64. PubMed ID: 17201802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative stimulated thyroglobulin level and recurrence risk stratification in differentiated thyroid cancer.
    Yang X; Liang J; Li TJ; Yang K; Liang DQ; Yu Z; Lin YS
    Chin Med J (Engl); 2015 Apr; 128(8):1058-64. PubMed ID: 25881600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma.
    Giovanella L; Ceriani L; Suriano S; Ghelfo A; Maffioli M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):659-63. PubMed ID: 18363882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial Thyroglobulin Variation Trend Shortly after Radioiodine Therapy in Poorly to Moderately Differentiated Recurrent Thyroid Cancer.
    Li CX; Hou M; Ren C; Lin YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Jun; 38(3):351-5. PubMed ID: 27469925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of radioiodine therapy and prognostic factors of differentiated thyroid cancer patients with pulmonary metastasis: An 8-year retrospective study.
    Wang R; Zhang Y; Tan J; Zhang G; Zhang R; Zheng W; He Y
    Medicine (Baltimore); 2017 May; 96(19):e6809. PubMed ID: 28489758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to Therapy Assessment in Intermediate-Risk Thyroid Cancer Patients: Is Thyroglobulin Stimulation Required?
    Moreno I; Hirsch D; Duskin-Bitan H; Dicker-Cohen T; Shimon I; Robenshtok E
    Thyroid; 2020 Jun; 30(6):863-870. PubMed ID: 31928205
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognostic Implications of Preablation Stimulated Tg: A Retrospective Analysis of 2500 Thyroid Cancer Patients.
    Tian T; Xu Y; Zhang X; Liu B
    J Clin Endocrinol Metab; 2021 Oct; 106(11):e4688-e4697. PubMed ID: 34143886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of differentiated thyroid cancer with rising thyroglobulin and negative diagnostic radioiodine whole body scan.
    Chao M
    Clin Oncol (R Coll Radiol); 2010 Aug; 22(6):438-47. PubMed ID: 20561773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcome of Remnant Thyroid Ablation with Low Dose Radioiodine in Korean Patients with Low to Intermediate-risk Thyroid Cancer.
    Ha S; Oh SW; Kim YK; Koo do H; Jung YH; Yi KH; Chung JK
    J Korean Med Sci; 2015 Jul; 30(7):876-81. PubMed ID: 26130949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyroglobulin assay during thyroxine treatment in low-risk differentiated thyroid cancer management: comparison with recombinant human thyrotropin-stimulated assay and imaging procedures.
    Giovanella L; Ceriani L; Ghelfo A; Keller F; Sacchi A; Maffioli M; Spriano G
    Clin Chem Lab Med; 2006; 44(5):648-52. PubMed ID: 16681439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in children and adolescents with differentiated thyroid cancer treated with total thyroidectomy and radioiodine therapy: a retrospective two-center study from China.
    Wang C; Li Y; Wang G; Liu X; Zhang Y; Lu C; Li J; Han N; Wang Z; Si Z; Li F; Lu G; Wang R; Wang X
    Front Endocrinol (Lausanne); 2024; 15():1419141. PubMed ID: 39104809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-suppressed thyrotropin and elevated thyroglobulin are independent predictors of recurrence in differentiated thyroid carcinoma.
    Böhm J; Kosma VM; Eskelinen M; Hollmen S; Niskanen M; Tulla H; Alhava E; Niskanen L
    Eur J Endocrinol; 1999 Nov; 141(5):460-7. PubMed ID: 10576761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of post-ablation stimulated thyroglobulin in differentiated thyroid cancer patients with biochemical incomplete response: a bi-center observational study.
    Wang Y; Wu J; Jiang L; Zhang X; Liu B
    Endocrine; 2022 Apr; 76(1):109-115. PubMed ID: 35094313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.